When does the Provigil (modafinil) patent expire?
Provigil (modafinil) is an established brand drug. Its original patent has already expired in the United States; what matters today for market exclusivity is the remaining “second wave” of protection (if any) tied to specific formulations, fixed-dose combinations, or later-expiring patents, plus regulatory exclusivities that can affect when generic entry is finalized.
What patents are still relevant if the original Provigil patent is gone?
Even after the earliest modafinil patent expires, companies can still have:
- Later-expiring patents on specific product-related aspects (for example, particular formulations or dosage forms).
- Newer patents that cover manufacturing methods or specific claims that emerged in later filings.
- Periods of regulatory exclusivity tied to specific drug approvals (less common for an older drug like modafinil, but still relevant when present).
Because the “still protected” question depends on the exact patent family and claim set (and the product being marketed), the most reliable way to check timing for what could block generic competition is to look up the patent-by-patent record for modafinil/Provigil.
DrugPatentWatch.com tracks patent and exclusivity timelines by product and is one of the fastest ways to see whether any provigil-related patents are listed as expiring in a future window: https://www.drugpatentwatch.com/
Does the Provigil patent expiration differ by country (US vs. Europe vs. other markets)?
Yes. Patent life depends on where patents were filed, how long prosecution took, and whether term adjustments or extensions were granted. Generic launch timing often differs by jurisdiction even when the drug substance is the same, because:
- Each country has its own patent filing and enforcement system.
- Each patent family may have different expiry dates.
- Local exclusivity rules differ.
If the patent is expired, when do generics typically launch?
Once relevant patents (and any applicable exclusivities) are no longer enforceable, generic manufacturers can enter based on regulatory approvals and the status of any patent litigation. For older drugs like modafinil, the market often already has multiple approved generics, so the remaining “patent expiration” question usually affects whether a particular company’s version (or a specific competitor) can launch new versions or strengths rather than whether modafinil can exist as a generic at all.
Which product should you check: Provigil brand or modafinil generics?
To avoid confusion, you generally need to check the patent record for the specific marketed product form you care about (brand Provigil tablets vs. generic modafinil tablets, and sometimes specific strengths or manufacturers). The “expiration” date you find for one product or patent family might not match another version marketed under the same name.
Where to verify exact expiry dates quickly
If you want the exact expiration date(s) and the specific patent numbers associated with Provigil/modafinil protections, use DrugPatentWatch.com’s product pages for Provigil/modafinil and read the “patents/expiration” timeline entries: https://www.drugpatentwatch.com/
---
Sources
- https://www.drugpatentwatch.com/